피플바이오
561KRWMarket close of 10/21 (Wed)
No trade that dayMarket close of 10/21 (Wed)
- Volume
- 0×10K shares
- 0 KRW
Open, high and low are not shown — the source has no bar for the reference date
Market close of 10/21 (Wed)
Where it sits in the 1-year range
0%0% of the way up from the lowest close in 1 year (252 sessions) · -79.1% from the high
Something to check
2 to check: no trades this day · operating loss
Free · no sign-inSource from 2021-05-17
Points to check
- Daily moveto checkNo trades this day (0 shares)
- Earningsto check-7.3B KRWOperating income over the last four quarters -7.3B KRW (loss)
- Trading valuenot verifiedNo trading that day, so not compared with usual trading value
The other 3
- Recent filingsnot verified
- Foreign & institutionalnot verified
- Data date10/21 (Wed)Market close
See the full check report
Quarterly results · Q1 2026
- Revenue643.27 million KRW
- vs. year ago
- -17.5%
- vs. prior quarter
- +319.0%
- Operating income-1.5B KRW
- vs. year ago
- Still a loss
- vs. prior quarter
- Still a loss
- Operating margin-230.5%
- vs. year ago
- +102.1 pp
- vs. prior quarter
- +903.3 pp
Quarterly operating income trend
As of the latest official close · 2026-10-21Valuation filing date · 2026-05-15Same sector · 제약
Up +0.83%· 57 of 168 stocks up, preferred shares excluded · trading value 730.8B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 삼성바이오로직스 | Close over the last 20 sessions +1.5% | Up +1.87% | 166.1B KRW |
| 셀트리온 | Close over the last 20 sessions +9.6% | Up +0.10% | 119.2B KRW |
| 지투지바이오 | Close over the last 20 sessions +27.6% | Up +13.78% | 49.8B KRW |
| 삼익제약 | Close over the last 20 sessions -20.3% | Up +2.58% | 47.2B KRW |
| 유한양행 | Close over the last 20 sessions +11.7% | Up +0.46% | 35.3B KRW |
Schedule
- Next data 10/23 (Fri) after 08:50
Investor flows, financials and valuation are provided for 369 stocks. These stocks account for about 85% of trading value, about 92% of market capitalisation. Coverage status →
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.